This HTML5 document contains 61 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/domain/vavai/projekt/
n6http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n5http://linked.opendata.cz/ontology/domain/vavai/
n13http://linked.opendata.cz/resource/domain/vavai/zamer/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F68378050%3A_____%2F01%3A23010376%21RIV%2F2003%2FAV0%2FA23003%2FN/
n8http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n18http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n7http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n17http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n15http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n16http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F68378050%3A_____%2F01%3A23010376%21RIV%2F2003%2FAV0%2FA23003%2FN
rdf:type
n5:Vysledek skos:Concept
dcterms:description
In two tumour models, 3MC-induced MHC class I + sarcoma Mc12 HPV 16 E6/E7 oncogene-induced MHC class I - carcinoma MK16, the effectiveness of combined chemoimmunotherapy with ifosfamide derivative CBM-4A and GM-CSF was investigated. In both types of tumours, the combined chemoimmunotherapy can inhibit tumour progression more effectively than GM-CSF therapy or chemotherapy alone. In two tumour models, 3MC-induced MHC class I + sarcoma Mc12 HPV 16 E6/E7 oncogene-induced MHC class I - carcinoma MK16, the effectiveness of combined chemoimmunotherapy with ifosfamide derivative CBM-4A and GM-CSF was investigated. In both types of tumours, the combined chemoimmunotherapy can inhibit tumour progression more effectively than GM-CSF therapy or chemotherapy alone.
dcterms:title
Chemoimmunotherapy of cancer: potentiated effectiveness of granulocyte-macrophage colony-stimulating factor and ifosfamide derivative CBM-4A. Chemoimmunotherapy of cancer: potentiated effectiveness of granulocyte-macrophage colony-stimulating factor and ifosfamide derivative CBM-4A.
skos:prefLabel
Chemoimmunotherapy of cancer: potentiated effectiveness of granulocyte-macrophage colony-stimulating factor and ifosfamide derivative CBM-4A. Chemoimmunotherapy of cancer: potentiated effectiveness of granulocyte-macrophage colony-stimulating factor and ifosfamide derivative CBM-4A.
skos:notation
RIV/68378050:_____/01:23010376!RIV/2003/AV0/A23003/N
n3:strany
1371;1374
n3:aktivita
n12:P n12:Z
n3:aktivity
P(GA301/00/0114), P(GA301/01/0985), P(GA312/99/0542), P(IAA7052002), P(NC5526), P(NC5900), Z(AV0Z5052915)
n3:cisloPeriodika
6
n3:dodaniDat
n16:2003
n3:domaciTvurceVysledku
n6:1572830 n6:9414185 n6:3714977 n6:4531140 n6:1723758 n6:6215319
n3:druhVysledku
n15:J
n3:duvernostUdaju
n18:S
n3:entitaPredkladatele
n11:predkladatel
n3:idSjednocenehoVysledku
675516
n3:idVysledku
RIV/68378050:_____/01:23010376
n3:jazykVysledku
n7:eng
n3:klicovaSlova
chemoimmunotherapy; - murine; - neoplasms
n3:klicoveSlovo
n8:chemoimmunotherapy n8:-%20neoplasms n8:-%20murine
n3:kodStatuVydavatele
GR - Řecká republika
n3:kontrolniKodProRIV
[54CFA84730B7]
n3:nazevZdroje
Oncology Reports
n3:obor
n17:EB
n3:pocetDomacichTvurcuVysledku
6
n3:pocetTvurcuVysledku
11
n3:pocetUcastnikuAkce
0
n3:pocetZahranicnichUcastnikuAkce
0
n3:projekt
n10:NC5526 n10:NC5900 n10:GA312%2F99%2F0542 n10:GA301%2F00%2F0114 n10:IAA7052002 n10:GA301%2F01%2F0985
n3:rokUplatneniVysledku
n16:2001
n3:svazekPeriodika
8
n3:tvurceVysledku
Jandlová, Táňa Bubeník, Jan Radzikowski, C. Indrová, Marie Glazman-Kusnierczyk, H. Mikyšková, Romana Pajtasz-Piasecka, E. Vonka, V. Šmahel, M. Šímová, Jana Bieblová, Jana
n3:zamer
n13:AV0Z5052915
s:issn
1021-335X
s:numberOfPages
4